The Pharmacy Times® Skin Cancer Resource Center is a comprehensive resource for clinical news and expert insights on cancers that occur on the skin, including basal cell carcinoma, squamous cell carcinoma, and melanoma.
July 24th 2025
Particularly during summer months, counsel patients about sunscreen recommendations and drug-induced photosensitivity prevention strategies.
HOPA 2025: Advancements and Challenges in Neoadjuvant Therapy for Regional Melanoma
April 11th 2025Christine Barrett, PharmD, BCOP, addressed advances in the treatment of stage III melanoma that provide the potential to improve long-term outcomes by enhancing immune response, tailoring surgical approaches, and refining patient selection strategies.
Read More
Lifileucel Approval Paves the Way for Personalized Minimally-Invasive T-Cell Therapies
February 25th 2025The FDA’s accelerated approval of lifileucel (Amtagvi; Iovance Biotherapeutics) marks a major milestone in immunotherapy for metastatic melanoma, building on decades of research in tumor-infiltrating lymphocyte therapy.
Read More
James P. Allison and the Discovery of CTLA-4: How Immune Checkpoint Blockade Revolutionized Oncology
February 25th 2025Immunotherapy pioneer James P. Allison, PhD, revolutionized cancer treatment by discovering immune checkpoint blockade, leading to significant advances in survival rates and ongoing efforts to optimize immuno-oncology strategies.
Read More
Updates in Cancer Prevention and Screening for 2025: A Pharmacist Primer
January 12th 2025Pharmacists play a vital role in cancer prevention and early detection by educating patients on risk factors, counseling on screening guidelines, and promoting adherence to evidence-based recommendations for common cancers, such as breast, cervical, colorectal, lung, prostate, and skin cancer.
Read More
An ESMO 2024 presentation explores the growing role of the gut microbiome in immunotherapy response, emerging diagnostic tools such as PCR chips, and innovative therapies such as fecal microbiota transplantation and microbiome-preserving strategies to improve patient outcomes.
Read More
Impact of PD-1 and PD-L1 Expression on Overall Survival in Patients With NSCLC and Melanoma
Pharmacists play a vital role in therapy selection.
Read More